Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
Expert Review of Medical Devices
|
July 4, 2009
Artificial pancreas: an emerging approach to treat Type 1 diabetes
Kavita Kumareswaran, Mark L Evans, Roman Hovorka
Environmental Monitoring and Assessment
|
November 26, 2005
Evaluation of lead availability in amended soils monitored over a long-term time period
Edwin F Barth, Paul A Succop, Mark L Evans
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 9, 2021
Implementation of dapagliflozin as adjunctive therapy in type 1 diabetes: A single centre real-world experience
Arjun Raj, Vishakha Bansiya, Mark L Evans, et al.
Plos One
|
December 14, 2011
BAD modulates counterregulatory responses to hypoglycemia and protective glucoprivic feeding
Mayowa A Osundiji, Marina L Godes, Mark L Evans, et al.
Endocrinology
|
March 8, 2012
Recurrent hypoglycemia is associated with loss of activation in rat brain cingulate cortex
Paul Hurst, Alastair S Garfield, Claire Marrow, et al.
Behavioural Brain Research
|
February 26, 2014
Distribution of cells responsive to 5-HT₆ receptor antagonist-induced hypophagia
Alastair S Garfield, Luke K Burke, Jill Shaw, et al.
Diabetes, Obesity & Metabolism
|
June 14, 2023
Sumatriptan, a serotonin 5HT<sub>1B</sub> receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double-blinded placebo-controlled cross-over trial
Rajna Golubic, Mouhamad Hussein Ismail, Masa Josipovic, et al.
Endocrinology
|
September 15, 2011
Neuropeptide Y cells represent a distinct glucose-sensing population in the lateral hypothalamus
Oliver J Marston, Paul Hurst, Mark L Evans, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 7, 2013
5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated
Barbora Doslikova, Alastair S Garfield, Jill Shaw, et al.
Diabetes Care
|
June 23, 2016
Exhaled Breath Isoprene Rises During Hypoglycemia in Type 1 Diabetes
Sankalpa Neupane, Robert Peverall, Graham Richmond, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
Expert Review of Medical Devices
|
July 4, 2009
Artificial pancreas: an emerging approach to treat Type 1 diabetes
Kavita Kumareswaran, Mark L Evans, Roman Hovorka
Environmental Monitoring and Assessment
|
November 26, 2005
Evaluation of lead availability in amended soils monitored over a long-term time period
Edwin F Barth, Paul A Succop, Mark L Evans
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 9, 2021
Implementation of dapagliflozin as adjunctive therapy in type 1 diabetes: A single centre real-world experience
Arjun Raj, Vishakha Bansiya, Mark L Evans, et al.
Plos One
|
December 14, 2011
BAD modulates counterregulatory responses to hypoglycemia and protective glucoprivic feeding
Mayowa A Osundiji, Marina L Godes, Mark L Evans, et al.
Endocrinology
|
March 8, 2012
Recurrent hypoglycemia is associated with loss of activation in rat brain cingulate cortex
Paul Hurst, Alastair S Garfield, Claire Marrow, et al.
Behavioural Brain Research
|
February 26, 2014
Distribution of cells responsive to 5-HT₆ receptor antagonist-induced hypophagia
Alastair S Garfield, Luke K Burke, Jill Shaw, et al.
Diabetes, Obesity & Metabolism
|
June 14, 2023
Sumatriptan, a serotonin 5HT<sub>1B</sub> receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double-blinded placebo-controlled cross-over trial
Rajna Golubic, Mouhamad Hussein Ismail, Masa Josipovic, et al.
Endocrinology
|
September 15, 2011
Neuropeptide Y cells represent a distinct glucose-sensing population in the lateral hypothalamus
Oliver J Marston, Paul Hurst, Mark L Evans, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 7, 2013
5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated
Barbora Doslikova, Alastair S Garfield, Jill Shaw, et al.
Diabetes Care
|
June 23, 2016
Exhaled Breath Isoprene Rises During Hypoglycemia in Type 1 Diabetes
Sankalpa Neupane, Robert Peverall, Graham Richmond, et al.
Page
of 12